Envoy Medical (COCH) Non-Current Deferred Tax Liability (2023 - 2025)
Envoy Medical (COCH) reported Non-Current Deferred Tax Liability of -$276000.0 for Q4 2025, down 15.48% on a YoY basis from -$326554.5 in Q4 2024, and down 15.48% sequentially from -$239000.0 in Q4 2024.
Envoy Medical (COCH) Non-Current Deferred Tax Liability (2023 - 2025) Analysis & Trends
Envoy Medical (COCH) has 3 years of Non-Current Deferred Tax Liability data on file, last reported at -$276000.0 in Q4 2025.
- For the quarter ending Q4 2025, Non-Current Deferred Tax Liability fell 15.48% year-over-year to -$276000.0; the trailing twelve-month figure through Dec 2025 stood at -$276000.0 (down 15.48% YoY), and the FY2025 full-year result was -$276000.0, down 15.48% from the prior year.
- Non-Current Deferred Tax Liability fell to -$276000.0 in Q4 2025, from -$239000.0 in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of -$20000.0 in Q4 2023 to a low of -$276000.0 in Q4 2025.
- A 3-year average of -$178333.3 and a median of -$239000.0 in 2024 frame the typical range for Non-Current Deferred Tax Liability.
- Across the five-year window, Non-Current Deferred Tax Liability plunged 1095.0% in 2024 and slipped 15.48% in 2025, its largest moves.
- Tracing COCH's Non-Current Deferred Tax Liability over 3 years: stood at -$20000.0 in 2023, then sank by 1095.0% to -$239000.0 in 2024, then retreated by 15.48% to -$276000.0 in 2025.
- Business Quant data shows COCH's Non-Current Deferred Tax Liability at -$276000.0 in Q4 2025, -$239000.0 in Q4 2024, and -$20000.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Envoy Medical | 45.50 Mn | 20.25 Mn | -274,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -276,000.00 |
| Dec 31, 2025 | -276,000.00 |
| Dec 31, 2024 | -239,000.00 |
| Dec 31, 2024 | -239,000.00 |
| Dec 31, 2023 | -20,000.00 |
| Dec 31, 2023 | -20,000.00 |